ℹ️ This website is strictly for educational and informational purposes. We are not medical professionals and cannot provide dosage advice or medical guidance. Our RUO Policy
⚠️ Please consult with a qualified healthcare provider before using any substances.
MOTS-c Handling & Storage Protocol
📄 NovaVitality Peptides — Research Use Only (RUO)
Document ID: NV-HSP-MOTSC-2025v1
Effective Date: 09 December 2025
Classification: Internal Research Guidance — Not for Clinical or Regulatory Submission
🧪 MOTS-c (Mitochondrial ORF-derived Peptide, 16-aa)
Handling, Reconstitution & Storage Protocol
For In Vitro and Preclinical Laboratory Research Use Only
⚠️ WARNING: This protocol applies exclusively to research-grade MOTS-c (Catalogue: NV-MOTSC-10). This material is NOT for human or animal administration. Misuse violates the UK Human Medicines Regulations 2012, FDA 21 CFR §1271, and EU Directive 2001/83/EC.
1. Product Overview
| Parameter | Value |
|---|---|
| Peptide Name | MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) |
| Sequence | MRWQENQARGGLGLLG (N-terminal methionine included; amidated C-terminus standard) |
| Purity (HPLC) | ≥98% (typical batch: 98.5–99.4%) |
| Molecular Weight | 1724.03 g/mol (monoisotopic) |
| Appearance | White to off-white lyophilized powder |
| Solubility | Moderate in acidic aqueous buffers (e.g., 0.1% acetic acid in H₂O or 0.9% NaCl); poor in neutral pH water |
2. Pre-Handling Safety & Facility Requirements
✅ Required Before Use:
- Work within a certified Class II Biological Safety Cabinet (BSC) or laminar flow hood (ISO 5 environment).
- Wear appropriate PPE: lab coat, nitrile gloves, safety goggles.
- Ensure access to spill containment kit (absorbent pads, 70% ethanol, biohazard bag).
- Confirm institutional approval for peptide handling (e.g., local Chemical Hygiene Plan compliance).
🚫 Prohibited:
- Open vials outside controlled environments.
- Use in non-sterile or non-research contexts (e.g., personal supplementation).
- Store near volatile organics, strong oxidizers, or sources of UV light.
3. Reconstitution Procedure
3.1 Recommended Solvents
| Solvent | Use Case | Notes |
|---|---|---|
| 0.1% Acetic Acid in Sterile Water | Standard for cell culture assays | Optimal solubility; pH ≈ 3.5–4.0 |
| Bacteriostatic Water (0.9% NaCl + 0.9% Benzyl Alcohol) | Short-term in vitro work (<72h) | Preservative extends shelf-life at 4°C; avoid if benzyl alcohol interferes with assay |
| DMSO (≤10% final conc.) | Stock for high-concentration aliquots | Use only for intermediate stocks; dilute ≥100-fold into aqueous buffer before biological use |
📌 Tip: MOTS-c may form transient opalescence upon reconstitution — allow 5–10 min at RT with gentle swirling (no vortexing). Sonication (ice bath, 10–15 sec bursts) may aid dissolution.
3.2 Step-by-Step Reconstitution (10mg vial → 1 mg/mL stock)
- Centrifuge lyophilized vial briefly (5 sec) to collect powder.
- Wipe rubber stopper with 70% ethanol; allow to dry.
- Using a sterile syringe, add 10 mL of chosen solvent slowly down the vial wall.
- Gently rotate vial for 2–3 min until fully dissolved (no visible particulates).
- Aliquot immediately into sterile, low-binding microtubes (e.g., 100 µL × 100 tubes).
- Flash-freeze in liquid N₂ or dry ice/ethanol bath.
- Store per Section 4.
❗ Do not reconstitute entire 10mg vial if single-use doses are smaller — partial reconstitution minimises degradation.
4. Storage Recommendations
| Form | Temperature | Duration | Stability Notes |
|---|---|---|---|
| Lyophilized (unopened) | −20°C, desiccated, dark | ≥24 months | Keep in original amber vial with desiccant |
| Lyophilized (opened) | −20°C, sealed with parafilm + desiccant | ≤6 months | Minimise air exposure; purge with argon if possible |
| Reconstituted (aliquoted, frozen) | −80°C | ≥12 months | Avoid frost-free freezers (temperature cycling degrades peptide) |
| Reconstituted (refrigerated) | 2–8°C | ≤7 days | For bacteriostatic water solutions only; monitor for turbidity |
🔬 Stability Monitoring:
- Visual check: Discard if cloudiness, precipitation, or colour change (yellow/brown) occurs.
- For critical assays: Validate activity via pilot dose–response (e.g., AMPK phosphorylation in C2C12 myotubes) if stored >6 months.
5. Handling in Experimental Workflows
- Cell Culture: Filter-sterilize (0.22 µm PVDF) after reconstitution if not using pre-sterile solvents.
- In Vivo Rodent Studies: Only use under approved IACUC protocol. Inject within 2h of thawing; keep on ice.
- Analytical Work (HPLC/MS): Dilute in 0.1% FA in 50:50 ACN:H₂O for optimal peak shape. Avoid phosphate buffers (ion suppression).
6. Disposal
Dispose of unused peptide and contaminated materials as chemical-biological mixed waste, per local regulations (e.g., UK: COSHH-compliant hazardous waste stream). Do not pour down the sink.
7. Certificate of Analysis (CoA) & QC
Each batch includes:
- HPLC Chromatogram (C18, gradient elution)
- MALDI-TOF or ESI-MS mass confirmation
- Endotoxin level (typical: <1.0 EU/mg — not sterile or pyrogen-free)
- Water content (KF titration)
📥 Request your batch-specific CoA by emailing [email protected] with your order number and catalogue ID.
8. References (Selected Research)
- Lee et al. (2015). Cell Metabolism 21(3):441–448. (Original MOTS-c discovery)
- Reynolds et al. (2021). Nature Communications 12:3895. (Mechanism: folate-AMPK axis)
- Ming et al. (2023). Aging Cell 22(4):e13859. (Age-related metabolic rescue in mice)
📚 For protocol citations, please reference NovaVitality (2025). MOTS-c Handling & Storage Protocol v1.
✅ Document Prepared By: NovaVitality Ltd
📧 Contact: [email protected] | 🌐 novavitality.co.uk
© 2025 NovaVitality Ltd. All rights reserved. This document is the property of NovaVitality and may not be redistributed without written permission.
